• Thurs news: GSK inks 2nd neuro pact in weeks. Teva episodic migraine trial. FDA clears AZ’s Imfinzi for aggressive lung cancer. Novartis fails to block generic Entresto. Nuvig gets immune drug funding. See more on our front page

Kaleo can't stay out of trouble













Worse than ever, been here through it all and have never seen anything like it is now. No one making their commission, I’m set to make $2,700 lmfao. I worked my ass off it’s an embarrassment to the industry. We all now this place is so yesterday.
Trust me they will adjust it again they have to every single payout or no one makes anything. Ass clowns